
What does it actually take to turn an idea into a biotech company?Aimee Raleigh, PhD, Principal at Atlas Venture, joins Mike and Jen as she walks through how companies get built before they’re even companies. From evaluating early science to forming a real point of view, Aimee shares how investors build conviction at the earliest stages.We get into the pace of early-stage venture, how to juggle multiple opportunities, make decisions with imperfect data, figure out what’s worth leaning into, and more. Aimee discusses her path into venture and what she’s learned along the way in an industry that doesn’t slow down.Listen and be prepared to walk away seeing early-stage ventures a little differently.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

From Scalpel to Term Sheet: Rich Gaster on Building Conviction, Backing Winners, and Fighting for Claire

Anna French on Building Qiming in the States and the Global Future of Biotech

Risk, Rigor, and Reality: Suan Tuang on Investing Across Private and Public Biotech

The Science of Company Building: A Conversation with Third Rock’s Noreen Rizvi
Free AI-powered recaps of The NextGen VC Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.